Breaking News: BioStem Technologies to Acquire Majority of Assets from AuxoCell Laboratories Inc.
BioStem Technologies to Acquire Majority of Assets of Auxocell Laboratories, Inc. POMPANO BEACH, FLORIDA., March 07, 2023 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (“BioStem” or the “Company”) (OTCQB: BSEM), announced today that it has entered into an Agreement to acquire the majority of the assets of Auxocell Laboratories, Inc. (“Auxocell”), a leading solid tissue processing…